Therapeutic issues with, and long-term outcomes of, pulmonary mycobacterial tuberculosis treatment in patients with autoimmune rheumatic diseases | Zendy

Dong Won Park | Zendy; Sung Jun Chung | Zendy; Yoomi Yeo | Zendy; Tai Sun Park | Zendy; Hyun Lee | Zendy; JiYong Moon | Zendy; SangHeon Kim | Zendy; TaeHyung Kim | Zendy; Ho Joo Yoon | Zendy; Jang Won Sohn | Zendy

Open Access

Therapeutic issues with, and long-term outcomes of, pulmonary mycobacterial tuberculosis treatment in patients with autoimmune rheumatic diseases

Author(s) -

Dong Won Park,

Sung Jun Chung,

Yoomi Yeo,

Tai Sun Park,

Hyun Lee,

JiYong Moon,

SangHeon Kim,

TaeHyung Kim,

Ho Joo Yoon,

Jang Won Sohn

Publication year - 2019

Publication title -

journal of thoracic disease

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.682

H-Index - 60

eISSN - 2077-6624

pISSN - 2072-1439

DOI - 10.21037/jtd.2019.10.74

Subject(s) - medicine , pulmonary tuberculosis , tuberculosis , immunology , term (time) , intensive care medicine , pathology , physics , quantum mechanics

Real-world data on treatment safety and outcome of pulmonary tuberculosis (PTB) in patients with rheumatic diseases (RDs) are scarce. This study explored the therapeutic issues of standard first-line anti-tuberculosis (TB) medication in patients in whom PTB complicated autoimmune RDs.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research